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Summary
Objectives: To assess the incidence and impact on treatment and prognosis of occult lymph
node metastasis in laryngeal cancer.
Patients and methods: A retrospective study was performed on 164 patients treated for laryn-
geal cancer, initially classiﬁed as N0, with cervical lymph node dissection.
Results: Occult metastases were found in 41 neck specimens (12.5%) from 32 patients (19.5%).
Involvement per neck level was: 7% level IIa, 2.4% IIb, 4.2% III and 2.7% IV. Lymph node involve-
ment was signiﬁcantly increased in case of T3T4 tumor or invasion of the pre-epiglottic space
or cartilage. Survival was signiﬁcantly inﬂuenced by pN status (pN- = 12 years, vs pN+ = 9 years;
P = 0.006).
Conclusion: Level IIb or IV involvement is rare. Superselective neck dissection (IIa, III) seems to
be indicated in T1T2 N0 tumor. In case of advanced tumor or pre-epiglottic space or cartilage
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Introduction
In laryngeal as in all upper aerodigestive tract cancer,
lymph node metastasis is an important prognostic factor, and
adapted treatment is critical to management and prognosis.Achieving earlier diagnosis of the laryngeal tumor
increases the frequency of patients presenting stage N0
lymph node involvement. Optimal management of N0
cases is controversial. Functional neck dissection entails
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non-negligible risk of nervous and lymphatic morbidity,
specially when applied to levels IIb and IV [1]. As these are
he least frequently affected levels, the advisability of dis-
ection is questionable, given advances in various diagnostic
trategies.
The present retrospective study of 164 patients, oper-
ted on in ﬁrst intention for stage-N0 laryngeal squamous
ell cancer, assessed the incidence of occult lymph node
etastasis, and sought to determine predictive factors and
mpact on treatment and prognosis.atients and methods
atients who had undergone lymph node neck dissection for
aryngeal squamous cell cancer, classiﬁed as stage N0 at
.
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Table 1 Tumor sublocations (n = 164).
Sublocation Number %
Supraglottic 7 4.2
Glottic 8 4.8
Subglottic 2 1.2
Glotto-supraglottic 55 33.5
Glotto-subglottic 8 4.8
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(Table 3).Transglottic 84 51.2
Total 164 100
iagnosis, over an 18-year period (1990 through 2007) were
etrospectively studied.
There were 164 patients: 5 female, 159 male; mean age,
2 years (range, 35—87 yrs).
All patients were pre-operatively classiﬁed as stage N0:
.e., absence of cervical adenopathy on physical exami-
ation and imaging. Patients classiﬁed as N0 on clinical
ssessment and with radiology (CT or US) indicating benign
ymph node status [2] were also counted as being at stage
0.
Tumors were T1 in 7.3% of cases (n = 12), T2 in 14.6%
n = 24) and T3T4 in 78% (n = 128). Table 1 presents tumor
ublocations.
Systematic bilateral functional neck dissection was the
avored attitude in all cases of laryngeal cancer except for
1 glottic lesions. All patients in the present series had
ndergone bilateral neck dissection, removing levels II, III
nd IV. Level VI dissection was performed in case of subglot-
ic involvement (n = 34).
Dissection specimens, removed as a single piece, were
ocated and sent for anatomopathology. All nodes were
xamined whole by series of 5 cross-sections, without
mmunohistochemical analysis, to determine the presence/
bsence, number and location of metastases.
Postoperative radiotherapy was prescribed in 123 cases
75%). Mean follow-up was 36 months.
Certain tumor parameters were explored for predic-
ive factors of occult lymph-node involvement: tumor
lass and site, pre-epiglottic space involvement, car-
ilage lysis, extralaryngeal extension, and histologic
ype.
Statistical analysis used SPSS 13.0 software, and com-
rised uni- and multi-variate analysis. In multivariate
nalysis, the Cox model speciﬁed parameters impacting
y
=
n
Table 2 Prediction factors for lymph node involvement.
Factors analyzed pN negative (n = 132) pN
Number %
Tumor class T3T4 96 72.7
Supraglottic invasion 114 86.3
Pre-epiglottic space involvement 20 15.1
Cartilage involvement 55 41.6
Extralaryngeal extension 22 16.6
Histologic type poorly or moderately
differentiated
33 25M. Mnejja et al.
verall survival. Overall survival was assessed by the Kaplan-
eier method, and survival curves were compared by
og-rank test. The signiﬁcance threshold was set at 5%.
esults
ll 164 patients underwent bilateral neck dissection
emoving levels II, III and IV. 328 specimens were thus ana-
yzed.
Occult metastases were detected in 41 specimens (12.5%)
rom 32 patients (19.5%). Capsule rupture was found in
0 specimens (3%). Metastases were bilateral in 9 patients
5.5%) and otherwise ipsilateral to the tumor (23 patients,
4%).
The distribution of levels IIa, IIb, III and IV in the 328
pecimens was respectively 7% (n = 23), 2.4% (n = 8), 4.2%
n = 14) and 2.7% (n = 9).
In the 32 patients with occult lymph node metas-
ases, the tumor was systematically graded T3 or T4, and
ever T1 or T2. The tumor was transglottic in 15 cases
47%), supraglottic in 11 (34%) and glotto-subglottic in 6
19%).
The rate of level IIb involvement in stage T3 and T4 tumor
as respectively 2.7% (4/146) and 3.6% (4/110). Level IV
howed invasion in 1.36% of T3 (2/146) and 6.3% of T4 tumors
7/110).
Statistical research for predictive factors showed that
re-epiglottic space and cartilage invasion correlated signif-
cantly with lymph node involvement in T3 and in T4 tumor
P = 1.5× 10−7, 8× 10−5 and 6× 10−3, respectively). No such
orrelation emerged for supraglottic involvement (P = 0.07),
xtralaryngeal extension (P = 0.06) or histologic type (differ-
ntiation) (P = 1) (Table 2).
Complications secondary to dissection were: lymphor-
hea in 4 cases (1.2%) and spinal nerve damage in 13 (4%).
After treatment in case of occult lymph node metastasis,
umor recurrence was observed in 4 cases (12.5%), recur-
ence of lymph node involvement in 2 (6.25%) and remote
etastasis in 4 (12.5%).
Comparison of tumor and lymph node recurrence and
emote metastasis between patients with and without occult
ymph node metastasis found no signiﬁcant differencesMean survival in pN- patients was 12 years, and 9
ears in pN+ patients; this difference was signiﬁcant (P
0.006) (Fig. 1). Multivariate Cox analysis showed lymph
ode involvement to have a signiﬁcant (P = 0.01) prognostic
positive (n = 32) Total (n = 164) P-value
Number % Number %
32 100 128 78 1.5× 10−37
32 100 146 89 0.07
15 46.8 35 21.3 8× 10−5
22 68.7 77 47 6× 10−3
10 31.2 32 19.5 0.06
8 25 41 25 1
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Table 3 Locoregional and remote evolution according to lymph node status.
pN negative (n = 132) pN positive (n = 32) Total (n = 164) P-value
Number % Number % Number %
Tumor recurrence 7 5.3 4 12.5 11 6.7 0.09
Lymph node recurrence 2 1.5 2
Remote metastasis 8 6 4
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adenopathy.Figure 1 Overall survival curve according to lymph node sta-
tus (Kaplan Meier calculation and comparison of curves by log
rank test).
impact, unlike advanced tumor stage (P = 0.8).
Discussion
The role and type of neck dissection in clinically graded
N0 laryngeal cancer remain controversial. The procedure
of choice used to be complete functional neck dissec-
tion removing levels I through V, with associated morbidity
mainly concerning spinal nerve, deep cervical plexus and
thoracic canal damage. Dissection was later limited to lev-
els II, III and IV (‘‘selective neck dissection II-IV’’, according
to the Committee for Head and Neck Surgery and Oncology
of the American Academy of Otolaryngology—Head and Neck
Surgery [3]), given the rarity of level I or V involvement.
More recently, certain authors argued against dissecting lev-
els IIb and IV in N0 tumor, to reduce associated morbidity;
others consider the occult lymph node metastasis rate to be
non-negligible (37% in Shah’s series [4]), and that functional
dissection is the appropriate attitude to prevent regional
recurrence.
The question arises as to whether there exist any selec-
tion criteria for patients in whom levels IIb and IV can be
conserved. This requires knowing the real distribution of
occult lymph node metastases in the various levels of the
neck. Rinaldo et al. [5] and Bolzoni et al. [6], analyzing data
from several prospective multicenter studies of N0 laryngeal
cancer, reported level IIb involvement in 1.4% of cases, sys-
tematically associated with involvement of another level.
Paleri et al. [1] concluded from a review of the literature
that level IIb was involved in only 0.4% of laryngeal squa-
mous cell carcinomas radiologically and clinically graded as
N0. All these studies agreed that level IIb dissection provided
no beneﬁt for patients free of palpable cervical adenopathy.
c
t
c6.25 4 2.4 0.11
12.5 12 7.3 0.18
n the present series, IIb involvement was found in 2.4% of
ases, systematically associated with IIa involvement.
Three prospective studies [7—9], including 175 patients
ith laryngeal cancer clinically graded as N0, reported
evel IV involvement in 6 patients: i.e., 3.4% of cases.
halif et al. [10], in a retrospective study of 71 patients,
eported a single case of level IV involvement, associ-
ted with level II involvement, and concluded that level
V dissection was not always required. Cagli et al. [11],
n a series of 58 cases of supraglottic cancer, showed that
evel IV involvement was never isolated. Van der Brekel
t al. [12] reported no cases of level IV involvement.
ccording to Ferlito et al. [13], level IV dissection is not
ndicated in supraglottic or glottic cancer clinically graded
s N0. In the present series, level IV involvement was
ound in 2.7% of cases (9/328), systematically associated
ith involvement of levels II and/or III. Certain authors
14] therefore recommend extemporaneous examination of
evels IIa and III; like others, however, we consider extem-
oraneous examination insufﬁciently sensitive to detect
icrometastases.
In subglottic cancer, metastasis is basically paratracheal,
nd requires level VI dissection; lateral dissection is unnec-
ssary [13].
Routine anatomopathology fails to diagnose metastases
maller than 2 or even 5mm [16]. Lymph node micrometas-
asis may thus be systematically underestimated. Burcia
t al. recommended sentinel lymph node biopsy with
mmunohistochemistry as the technique of choice, detect-
ng micrometastases with 100% sensitivity [16]. The interest
f this technique in laryngeal cancer remains as yet to be
emonstrated.
According to Rodrigo et al. [17] and Cagli et al. [18],
outine bilateral functional dissection is inappropriate in N0
1 and T2 supraglottic cancer, and should be reserved for
ilateral and medial lesions.
In the present study, advanced tumor stage (T3T4)
P < 10−3) and pre-epiglottic invasion (P < 10−3) emerged as
igniﬁcant risk factors for lymph node metastasis, whereas
ccult metastasis did not correlate with cartilage involve-
ent, extralaryngeal extension or histologic type.
Most literature reports recommend limiting the num-
er of levels removed, with superselective dissection to
emove only levels IIa and III. The present study suggests that
uperselective dissection should be reserved for T1 and T2
lottic and/or supraglottic tumor without palpable cervicalIn a prospective multicenter study, Brentani et al. [19]
oncluded that the type of dissection (selective vs. func-
ional) did not correlate with the rates of ipsilateral,
ontralateral or bilateral recurrence in the lymph nodes.
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eon et al. [20] reported no cases of failure of lymph node
reatment with dissection of levels II and III.
In the present study, occult lymph node metastasis did
ot correlate with elevated risk of locoregional recurrence
r remote metastasis. Regional evolution was observed in
nly 4 cases (2 pN- and 2 pN+; 2.4%), compared to 5.5%
f cases reported by Lim et al. [21]. Regional recurrence
ften involves levels II and III [18]. In the present study,
urvival was signiﬁcantly poorer in pN+ than pN- patients
n multivariate analysis, pN stage having greater prognostic
mpact than tumor stage.
onclusion
evel IIa and IV involvement in laryngeal cancer is rare and
ften associated with involvement of other levels. Superse-
ective (IIa and III) neck dissection seems indicated in N0 T1
nd T2 glottic and/or supraglottic tumor, limiting morbidity
ithout increasing risk of failure. In case of advanced tumor
T3 or T4) or pre-epiglottic space or cartilage involvement,
ccult lymph node invasion is more frequent and functional
issection is mandatory.
onﬂict of interest
one.
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